uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer.
Uppsala University, Medicinska vetenskapsområdet, Faculty of Medicine, Department of Oncology, Radiology and Clinical Immunology. Enheten för onkologi. (Gastro-BG)
Show others and affiliations
2004 (English)In: Br J Cancer, ISSN 0007-0920, Vol. 91, no 8, 1434-41 p.Article in journal (Other scientific) Published
Place, publisher, year, edition, pages
2004. Vol. 91, no 8, 1434-41 p.
Keyword [en]
Adenocarcinoma/*drug therapy/secondary, Adolescent, Adult, Aged, Antineoplastic Agents; Phytogenic/pharmacokinetics/*therapeutic use, Camptothecin/*analogs & derivatives/pharmacokinetics/*therapeutic use, Colorectal Neoplasms/*drug therapy/pathology, Comparative Study, DNA Topoisomerases; Type I/antagonists & inhibitors, Drug Administration Schedule, Female, Humans, Male, Middle Aged, Research Support; Non-U.S. Gov't, Survival Rate, Treatment Outcome
National Category
Cancer and Oncology
URN: urn:nbn:se:uu:diva-70041PubMedID: 15381932OAI: oai:DiVA.org:uu-70041DiVA: diva2:97952
Available from: 2005-04-14 Created: 2005-04-14 Last updated: 2011-01-12

Open Access in DiVA

No full text

Other links


Search in DiVA

By author/editor
Glimelius, Bengt
By organisation
Department of Oncology, Radiology and Clinical Immunology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 116 hits
ReferencesLink to record
Permanent link

Direct link